Atlas Trials

NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer

Clinical trial NCT00675012 · COMPLETED

Trial details

NCT number
NCT00675012
Sponsor
AGC Biologics S.p.A.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colon Cancer
Start date
2007-12-01
Primary completion
2010-12-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.